Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,368 | 262 | 69.9% |
| Travel and Lodging | $2,604 | 12 | 24.7% |
| Education | $566.25 | 14 | 5.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $2,434 | 46 | $0 (2023) |
| Coloplast Corp | $1,550 | 24 | $0 (2022) |
| Ethicon US, LLC | $1,248 | 42 | $0 (2022) |
| Astellas Pharma US Inc | $876.19 | 34 | $0 (2022) |
| NeoTract Inc. | $785.34 | 17 | $0 (2020) |
| Medtronic USA, Inc. | $579.93 | 11 | $0 (2019) |
| Janssen Biotech, Inc. | $492.82 | 18 | $0 (2022) |
| Teleflex LLC | $299.72 | 9 | $0 (2022) |
| Endo Pharmaceuticals Inc. | $293.24 | 10 | $0 (2022) |
| Axonics, Inc. | $199.07 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $60.35 | 3 | Sumitomo Pharma America, Inc. ($60.35) |
| 2023 | $179.39 | 4 | Axonics, Inc. ($134.28) |
| 2022 | $755.41 | 31 | Teleflex LLC ($180.60) |
| 2021 | $1,329 | 49 | Janssen Biotech, Inc. ($354.50) |
| 2020 | $908.12 | 40 | Boston Scientific Corporation ($226.47) |
| 2019 | $4,762 | 79 | Boston Scientific Corporation ($1,745) |
| 2018 | $1,423 | 45 | Ethicon US, LLC ($540.02) |
| 2017 | $1,121 | 37 | Ethicon US, LLC ($293.19) |
All Payment Transactions
288 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: UROLOGY | ||||||
| 09/25/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: UROLOGY | ||||||
| 08/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $25.91 | General |
| Category: UROLOGY | ||||||
| 09/29/2023 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $134.28 | General |
| Category: Urology | ||||||
| 07/12/2023 | 180 Medical, Inc. | GENTLECATH GLIDE (Device) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: CONTINENCE CARE | ||||||
| 07/06/2023 | Boston Scientific Corporation | Solyx SIS System (Device) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Solyx_URO | ||||||
| 02/16/2023 | Agiliti Surgical, Inc. | Sonablate (Device), SOLTIVE, Cryocare CS | Food and Beverage | Cash or cash equivalent | $16.35 | General |
| Category: Surgical lasers | ||||||
| 08/24/2022 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $80.04 | General |
| Category: Interventional Urology | ||||||
| 08/24/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Urology | ||||||
| 08/01/2022 | 180 Medical, Inc. | SPEEDICATH (Device) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: UROLOGICAL CARE | ||||||
| 07/28/2022 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $29.99 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 07/21/2022 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $52.74 | General |
| Category: Interventional Urology | ||||||
| 07/14/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $20.10 | General |
| Category: Urology | ||||||
| 07/13/2022 | Endo Pharmaceuticals Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: UROLOGY | ||||||
| 07/06/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Oncology | ||||||
| 06/16/2022 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $29.64 | General |
| Category: Oncology | ||||||
| 06/16/2022 | PFIZER INC. | XTANDI (Drug), ORGOVYX, PAXLOVID | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: ONCOLOGY | ||||||
| 06/02/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Oncology | ||||||
| 05/18/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Urology | ||||||
| 04/19/2022 | Acerus Pharmaceuticals Corporation | Natesto (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Urology Endocrinology Men's Health | ||||||
| 04/19/2022 | Acerus Pharmaceuticals Corporation | Natesto (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Urology Endocrinology Men's Health | ||||||
| 04/11/2022 | Rochester Medical Corporation | — | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Medical Systems | ||||||
| 04/07/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: Oncology | ||||||
| 04/07/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $14.89 | General |
| Category: Urology | ||||||
| 03/24/2022 | Teleflex LLC | UroLift System (Device) | Food and Beverage | In-kind items and services | $28.74 | General |
| Category: Interventional Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 200 | 231 | $30,997 | $14,116 |
| 2022 | 42 | 4,288 | 8,408 | $1.7M | $414,151 |
| 2021 | 36 | 4,637 | 7,720 | $2.1M | $497,688 |
| 2020 | 30 | 3,385 | 5,259 | $1.8M | $387,297 |
All Medicare Procedures & Services
114 procedure records from CMS Medicare Utilization — Page 2 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 81003 | Automated urinalysis test | Office | 2022 | 759 | 1,140 | $22,800 | $2,549 | 11.2% |
| 84403 | Testosterone (hormone) level, total | Office | 2022 | 74 | 100 | $8,900 | $2,534 | 28.5% |
| 82306 | Vitamin d-3 level | Office | 2022 | 65 | 86 | $7,310 | $2,495 | 34.1% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2022 | 22 | 45 | $13,500 | $2,123 | 15.7% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2022 | 13 | 16 | $36,000 | $1,964 | 5.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 16 | 17 | $6,375 | $1,871 | 29.4% |
| 86316 | Analysis for detection of tumor marker | Office | 2022 | 69 | 85 | $4,250 | $1,754 | 41.3% |
| 52224 | Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | Facility | 2022 | 11 | 11 | $38,500 | $1,690 | 4.4% |
| 87653 | Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | Office | 2022 | 44 | 46 | $4,140 | $1,609 | 38.9% |
| 84154 | Psa (prostate specific antigen) measurement, free | Office | 2022 | 70 | 85 | $8,500 | $1,550 | 18.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 20 | 20 | $7,500 | $1,313 | 17.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 34 | 35 | $9,625 | $1,260 | 13.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 235 | 258 | $6,450 | $766.35 | 11.9% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2022 | 14 | 21 | $7,435 | $669.12 | 9.0% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 27 | 28 | $3,080 | $612.73 | 19.9% |
| 82310 | Calcium level, total | Office | 2022 | 66 | 90 | $1,350 | $455.59 | 33.7% |
| 51701 | Insertion of temporary bladder tube | Office | 2022 | 13 | 14 | $2,800 | $452.11 | 16.1% |
| 82565 | Blood creatinine level | Office | 2022 | 66 | 70 | $1,400 | $350.83 | 25.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 17 | 25 | $2,250 | $275.05 | 12.2% |
| 84520 | Urea nitrogen level to assess kidney function, quantitative | Office | 2022 | 66 | 70 | $1,050 | $270.59 | 25.8% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 20 | 26 | $2,550 | $234.04 | 9.2% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2022 | 15 | 15 | $375.00 | $126.50 | 33.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 11 | 11 | $275.00 | $84.83 | 30.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 917 | 1,900 | $665,000 | $191,954 | 28.9% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 282 | 342 | $247,950 | $66,062 | 26.6% |
About Dr. Michael Corea, MD
Dr. Michael Corea, MD is a Urology healthcare provider based in Dedham, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1104813641.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Corea, MD has received a total of $10,538 in payments from pharmaceutical and medical device companies, with $60.35 received in 2024. These payments were reported across 288 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($7,368).
As a Medicare-enrolled provider, Corea has provided services to 12,510 Medicare beneficiaries, totaling 21,618 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 114 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Dedham, MA
- Active Since 09/30/2005
- Last Updated 01/16/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1104813641
Products in Payments
- INTERSTIM (Device) $760.82
- SOLYX (Device) $745.44
- ALTIS (Device) $744.37
- UroLift (Device) $650.02
- AMS (Device) $564.49
- AXIS (Biological) $440.23
- ERLEADA (Drug) $427.02
- HARMONIC Product Family (Device) $393.31
- ADVANTAGE FIT (Device) $385.33
- MYRBETRIQ (Drug) $314.82
- UROLIFT (Device) $268.10
- XIAFLEX (Biological) $264.92
- XTANDI (Drug) $195.16
- GENERAL - KIDNEY STONE DISEASE (Device) $188.21
- GEMTESA (Drug) $172.23
- EVICEL (Biological) $144.43
- Mega Power (Device) $136.05
- UroLift System (Device) $134.72
- Axonics (Device) $134.28
- Endocare Cryocare System (Medical Supply) $131.50
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.